AI Agents in Action: How Digital Colleagues Are Changing the Way We Work - On Record PR
Innovation in Compliance: Mastering Communication: Insights from Dr. Dennis Cummins on Speaking and Selling without Selling
Fox on Podcasting: PodPage and Beyond: Elevating Listener Experience with Dave Jackson
Innovation in Compliance: The Future of Compliance Training: AI, Adaptive, Learning, and Cultural
Can Food Really Be Medicine? Transforming Health Care One Bite at a Time – Diagnosing Health Care Video Podcast
The Rise of OTAs in Defense Contracting: Opportunities, Risks, and What Contractors Need to Know
Future-Ready – Equipping MBD Teams to Navigate and Leverage Emerging Technologies
AI in eDiscovery Today: An Open Conversation
Innovation in Compliance: Allison Lagosh on Proactive Compliance Planning for Regulatory Changes
Innovation in Compliance: Maximizing LinkedIn for Personal and Professional Branding with Carol Kaemmerer
Innovation in Compliance: The Critical Importance of Mobile Application Security: Insights from Subho Halder
Meet Phil Leslie, Cornerstone Research's New Chief Technology and Innovation Officer
Innovation in Compliance: Integrating AI in Compliance and Risk Management with Jana Brost
The Future of Supply Chains: Chris Andrassy on Using AI to Predict & Prevent Disruptions
Innovation in Compliance: Break the Five Lies - A Conversation with John Kormanik
Compliance Tip of the Day: Using Supply Chain to Innovate in Compliance
Innovation in Compliance: Innovative Approaches to Compliance and Training with Catherine Choe
Innovation in Compliance: Exploring the Fractional COO Model with La Tonya Roberts
Innovation in Compliance: Design-Centric Compliance Training with Karen Oddo
Innovation in Compliance: Strategic Compliance in Regulated Industries with Kerri Reuter
Key Points - - The war in Ukraine has prompted a historic surge in European defense spending. - Governments in the EU and U.K. are stressing the need for innovation. They are increasingly turning to investment in small...more
The European Commission (EC) is conducting a comprehensive review of its Merger Guidelines, supported by a broad public consultation. The review aims to determine whether the current framework remains suitable for assessing...more
The European Commission has launched a public consultation seeking feedback on its ongoing review of the 20+-year-old EU merger guidelines....more
The European Commission has launched a public consultation of its Horizontal and Non-Horizontal Merger Guidelines. Framed as a "comprehensive and ambitious" review, the Commission is exploring how to incorporate wider policy...more
A key objective outlined in Commissioner Ribera’s mission letter is the modernization of EU competition policy, including the framework employed by the European Commission (EC) to assess the competitive impact of mergers. In...more
The European Commission has published on the 29th January the “Competitiveness Compass for the EU”, setting out ambitious initiatives aimed at strengthening and protecting the EU’s position on global markets. The Compass...more
Medical device and diagnostics companies and laboratories should anticipate significant legal, regulatory and market changes in 2020 that will have a lasting impact on the industry. From revisions to how the government...more
On April 4, 2019, the European Commission published a report1 prepared by three special advisers (the Advisers) appointed by EU Competition Commissioner Margrethe Vestager to explore how EU competition policy should evolve in...more
Skadden’s Antitrust and Competition Group and the economics firm Charles River Associates recently co-hosted the ninth annual “Antitrust in the Technology Sector: Policy Perspectives and Insights From the Enforcers” seminar...more
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
The European Commission has routinely considered potential harm to innovation as part of its merger assessments, particularly in R&D driven sectors such as pharmaceuticals and technology. In recent years, however, the...more
Skadden’s Antitrust and Competition Group and the economics firm Charles River Associates recently hosted the eighth annual “Antitrust in the Technology Sector: Policy Perspectives and Insights From the Enforcers” seminar in...more
On October 25, 2016, McDermott Will & Emery held its fifth annual Pharmaceutical/Medtech Dealmaking Symposium in Cambridge, Massachusetts. The day consisted of a series of thought-provoking panels with leading dealmakers in...more